JAMES A. JOYCE, Chairman of Aethlon Medical. Mr. Joyce has led the
efforts that have resulted in the recent acquisitions of Hemex, Inc.,
Syngen Research, Inc., Cell Activation, Inc., and Bishop Equities, Inc.
Mr. Joyce founded Aethlon, Inc., the predecessor to Aethlon Medical in
May of 1998. In February of 1993, Mr. Joyce was the founder and Chief
Executive Officer of James Joyce & Associates; an organization that
provided management consulting and investment banking advisory services
to CEO’s and CFO’s of publicly traded companies. Selected transactions
include the structure and placement of over $20 million in private
equity on behalf of a publicly traded computer distribution company, and
management and advisory services which led to the successful Initial
Public Offering of a non-related biomedical company. Previously, Mr.
Joyce was Chief Executive Officer of Mission Labs, Inc., and a principal
in charge of US operations for London Zurich Securities, Inc. Mr. Joyce
graduated from the University of Maryland in 1984.
